Drug intelligence / Profile preview

ω-3 pufa + polyphenols + l-carnitine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

A combination supplement containing omega-3 polyunsaturated fatty acids (ω-3 PUFA), polyphenols, and L-carnitine is designed to target metabolic health. This formulation has been studied for its effects on lipid metabolism, energy production, and inflammation. Mechanistically, ω-3 PUFAs are known to reduce inflammation and modulate gene expression related to lipid metabolism; they serve as precursors for anti-inflammatory prostaglandins and can lower triglyceride levels. Polyphenols act as antioxidants with additional roles in modulating metabolic pathways. L-carnitine facilitates the transport of long-chain fatty acids into mitochondria for β-oxidation, enhancing fat utilization for energy. Clinical studies have shown that this combination can significantly reduce plasma free fatty acid and triglyceride concentrations while increasing the expression of genes involved in fatty acid oxidation (notably via peroxisome proliferator-activated receptor alpha [PPARα] activation). The combined effect is improved lipid profiles and enhanced cellular energy metabolism[1][5]. This supplement is primarily used as a dietary intervention in overweight or hyperlipidemic individuals to support weight loss, improve metabolic markers, and potentially benefit muscle function[1][2][4].

Other names
omega-3 polyunsaturated fatty acids + polyphenols + l-carnitinePPC combination
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)SLC7A1 (Cationic amino acid transporter 1)

Beyond the preview

Go deeper on ω-3 pufa + polyphenols + l-carnitine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ω-3 pufa + polyphenols + l-carnitine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call